top of page

Journal Articles

CMAJ - May 04, 2020
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline
Z. Ye, et. al.
NIH - April 20, 2020
NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
R. Gulick, H. Lane, H. Masur, et. al.
IDSA - April 11, 2020
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
A. Bhimraj, et. al.
ICM - Mar 28, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).
W. Alhazzani, et. al.
JAMA - Mar 11, 2020
Care for Critically Ill Patients With COVID-19
S. Murthy, et. al.
Potential Therapies
NEJM - May 22, 2020
Remdesivir for the Treatment of Covid-19 — Preliminary Report
JH Beigel, et. al.
Consider also:
PulmCrit - May 23, 2020
PulmCrit – Preliminary report on NIAID trial of remdesivir (ACTT-1)
Josh Farkas
Lancet - April 29, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Y. Wang, et. al.
Consider also:
PulmCrit - April 30, 2020
PulmCrit – First placebo-controlled RCT on remdesivir for COVID-19
Josh Farkas
medRxiv - April 14, 2020
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
W. Tang, et. al.
Consider also:
PulmCrit - April 16, 2020
PulmCrit – Hydroxychloroquine fails first meaningful RCT
Josh Farkas
NEJM - April 10, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein, et. al.
Consider also:
PulmCrit - April 11, 2020
PulmCrit – Eleven reasons the NEJM paper on remdesivir reveals nothing
Josh Farkas
NEJM - March 18, 2020
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao, et. al.
ICM - April 23, 2020
Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection
MC. Copin, et. al.
JAMA - March 4, 2020
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
SWX. Ong, et. al.
Case Reports/Case Series
JAMA - April 22, 2020
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
S. Richardson, et. al.
NEJM - April 17, 2020
Clinical Characteristics of Covid-19 in New York City (Correspondence)
P. Goyal, et. al.
Resuscitation - April 6, 2020
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China
F. Shao, et. al.
JAMA - April 6, 2020
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
G. Grasselli, et. al.
Lancet - Mar 28, 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
F. Zhou, et. al.
NEJM - Feb 28, 2020
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan, et. al.

Updated May 6, 2020

This page is no longer being updated regularly. Please note the date of each publication.
bottom of page